Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Preferred Shares Issued (2016 - 2017)

Historic Preferred Shares Issued for Altimmune (ALT) over the last 2 years, with Q3 2017 value amounting to $13.0 million.

  • Altimmune's Preferred Shares Issued rose 54862.92% to $13.0 million in Q3 2017 from the same period last year, while for Dec 2017 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $13.0 million for FY2017, which is 12945.55% up from last year.
  • According to the latest figures from Q3 2017, Altimmune's Preferred Shares Issued is $13.0 million, which was up 54862.92% from $2.0 million recorded in Q3 2016.
  • Altimmune's Preferred Shares Issued's 5-year high stood at $13.0 million during Q3 2017, with a 5-year trough of $2.0 million in Q3 2016.